propranolol has been researched along with Death, Sudden in 84 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective, randomised, double-blind study was performed to compare the effects of propranolol and placebo on sudden cardiac death in a high-risk group of patients who survived acute myocardial infarction." | 9.05 | One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. ( Andersen, A; Bakken, J; Dyrbekk, D; Eika, C; Hansteen, V; Hoff, PI; Knudsen, K; Lorentsen, E; Møinichen, E; Refsum, AM; Smith, P; Strøm, O; Søiland, K; Tromsdal, A, 1982) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a National Heart, Lung, and Blood Institute-sponsored, multicenter, randomized, double-blind, and placebo-controlled trial designed to test whether the regular administration of propranolol hydrochloride to men and women who had experienced at least one myocardial infarction would result in a significant reduction in total mortality during a two- to four-year period." | 9.05 | A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. ( , 1982) |
| "The natural history of and the effect of propranolol on ventricular arrhythmias post-myocardial infarction were analyzed using data from the Beta-Blocker Heart Attack Trial (BHAT)." | 9.05 | Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. ( Byington, R; Lichstein, E; Morganroth, J, 1985) |
| "Heavy male Sprague-Dawley rats die of ventricular fibrillation within 2 to 3 h after isoproterenol administration." | 7.67 | Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death. ( Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL, 1986) |
| "To provide insight into the protective effect of propranolol on mortality after myocardial infarction observed in the beta-Blocker Heart Attack Trial, the time of occurrence of sudden cardiac death was examined in this population." | 5.06 | Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience). ( Peters, RW, 1990) |
| "In the Beta Blocker Heart Attack Trial (BHAT), 3837 patients were randomized to propranolol (180-240 mg/day) or placebo 5-21 days after a documented myocardial infarction and were followed in a double blind manner for a mean period of 25 months." | 5.06 | Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group. ( Barker, A; Byington, RP; Peters, RW; Yusuf, S, 1990) |
| "In the Beta Blocker Heart Attack Trial, a double blind, randomized, controlled study, patients taking propranolol (180 or 240 mg/day) initiated 5-21 days post myocardial infarction had 26% fewer deaths than those taking placebo over a 25 month (mean) followup." | 5.06 | Mortality in the beta blocker heart attack trial: circumstances surrounding death. ( Arensberg, D; Barker, A; Byington, R; Friedman, LM; Goldstein, S; Laubach, C; Peters, RW; Romhilt, DW; Wilner, GW, 1987) |
| "The Beta Blocker Heart Attack Trial (BHAT) is a multicenter, randomized, double-blind, placebo control clinical trial sponsored by the National Heart, Lung, and Blood Institute designed to test the effectiveness of regular propranolol administration in reducing total mortality in patients who have survived a recent acute myocardial infarction." | 5.05 | Beta Blocker Heart Attack Trial: design features. ( , 1981) |
| "Recently completed Beta-Blocker Heart Attack Trial in which propranolol was administered to patients following an acute myocardial infarction resulted in a 26% decrease in total mortality and a 23% decrease in total coronary events in the propranolol-treated patients as compared to the placebo patients during the average follow-up of 25 months." | 5.05 | The Beta-Blocker Heart Attack Trial in perspective. ( Goldstein, S, 1983) |
| "A prospective, randomised, double-blind study was performed to compare the effects of propranolol and placebo on sudden cardiac death in a high-risk group of patients who survived acute myocardial infarction." | 5.05 | One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. ( Andersen, A; Bakken, J; Dyrbekk, D; Eika, C; Hansteen, V; Hoff, PI; Knudsen, K; Lorentsen, E; Møinichen, E; Refsum, AM; Smith, P; Strøm, O; Søiland, K; Tromsdal, A, 1982) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a National Heart, Lung, and Blood Institute-sponsored, multicenter, randomized, double-blind, and placebo-controlled trial designed to test whether the regular administration of propranolol hydrochloride to men and women who had experienced at least one myocardial infarction would result in a significant reduction in total mortality during a two- to four-year period." | 5.05 | A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. ( , 1982) |
| "The natural history of and the effect of propranolol on ventricular arrhythmias post-myocardial infarction were analyzed using data from the Beta-Blocker Heart Attack Trial (BHAT)." | 5.05 | Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. ( Byington, R; Lichstein, E; Morganroth, J, 1985) |
| "Heavy male Sprague-Dawley rats die of ventricular fibrillation within 2 to 3 h after isoproterenol administration." | 3.67 | Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death. ( Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL, 1986) |
| "The use of propranolol since the first hours of myocardial infarction reduced the perinecrotic zone and restricted the zone of myocardial necrosis, decreased the frequency of arrhythmias and did not produce heart insufficiency." | 3.67 | [Inderal in the acute and post-myocardial infarct periods]. ( Alushkov, MV; Martynov, IV; Popov, VG; Voronin, VA, 1986) |
| "This study was designed to investigate the relationships of myocardial concentrations of norepinephrine (NE) and cyclic AMP (c-AMP) to the development of ventricular fibrillation (VF) with reference to the effects of a premedication of dibutyryl cyclic AMP (DBC-AMP) and propranolol in dogs with experimental myocardial infarction." | 3.66 | Myocardial norepinephrine and cyclic amp concentration following myocardial ischemia--relation to ventricular fibrillation and sudden death. ( Ban, M; Kanayama, H; Ogawa, K; Ukai, M, 1983) |
| "with complicated infarctions or complex arrhythmias." | 2.66 | The Beta-blocker Heart Attack Trial. ( Furberg, CD, 1985) |
| "Ventricular arrhythmias during exercise and 8 minutes of recovery were studied." | 2.64 | The effect of coronary bypass surgery on exercise-induced ventricular arrhythmias. ( Barry, WH; Hultgren, HN; Lipton, MJ; Pfeifer, JF; Tilkian, AG, 1976) |
| "However, the incidence of sudden death and aborted sudden death (24% in all patients and 17% in compliant patients) strongly suggests the use of a "back-up" defibrillator, particularly in noncompliant adolescent patients." | 1.30 | Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. ( Belhassen, B; Dorostkar, PC; Eldar, M; Scheinman, MM, 1999) |
| "Dogs with an inherited predisposition to sudden death display ventricular arrhythmias having certain characteristics, such as pause dependence, that are suggestive of early afterdepolarization-induced triggered activity." | 1.29 | Phenylephrine-induced ventricular arrhythmias in dogs with inherited sudden death. ( Brittain, D; Flahive, WJ; Gilmour, RF; Lee, RJ; Lewis, BA; Moïse, NS; Moon, PF; Pride, HP; Zipes, DP, 1996) |
| "Forty-five patients survived a cardiac arrest due to ventricular tachycardia (VT) or ventricular fibrillation (VF)." | 1.27 | Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. ( Hess, DS; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| "The mechanisms underlying the cause of sudden death have not been clearly elucidated." | 1.27 | [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. ( Kleinebenne, A; McKenna, WJ, 1985) |
| "A patient with clinically silent mitral valve prolapse experienced an episode of out-of-hospital cardiac arrest due to ventricular fibrillation." | 1.27 | Ventricular fibrillation in a patient with 'silent' mitral valve prolapse. ( Agmon, J; Caspi, A; Kusniec, J; Lewin, RF; Sclarovsky, S; Strasberg, B, 1988) |
| "Malignant ventricular arrhythmias appearing during acute myocardial ischaemia, are the most frequent mechanism of sudden death." | 1.27 | Ventricular arrhythmias during acute myocardial ischaemia in man. The role and significance of R-ST-T alternans and the prevention of ischaemic sudden death by medical treatment. ( Campana, C; Chimienti, M; Falcone, C; Guasti, L; Klersy, C; Marangoni, E; Panciroli, C; Previtali, M; Regazzi Bonora, M; Salerno, JA, 1986) |
| "Thus, sudden death may be the first definitive manifestation of cardiac disease in some patients with hypertrophic cardiomyopathy." | 1.26 | Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. ( Edwards, JE; Epstein, SE; Foley, DD; Maron, BJ; McAllister, HA; Roberts, WC, 1978) |
| "Of particular importance are the arrhythmias observed immediately after experimentally induced acute myocardial infarction (AMI)." | 1.25 | Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system. ( Kniffen, FJ; Lucchesi, BR, 1975) |
| "The syncopal attacks are based on cardiac arrhythmias: both ventricular fibrillation and asystole may occur." | 1.25 | The surdo-cardiac syndrome and therapeutic observations. ( Fowler, RS; Olley, PM, 1970) |
| "About 7% died from cardiac arrhythmia four days or more after the onset of infarction." | 1.25 | Hospital mortality in acute myocardial infarction. ( Bensley, KE; Caughey, DE; Norris, RM; Scott, PJ, 1968) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 75 (89.29) | 18.7374 |
| 1990's | 8 (9.52) | 18.2507 |
| 2000's | 1 (1.19) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nademanee, K | 1 |
| Veerakul, G | 1 |
| Mower, M | 1 |
| Likittanasombat, K | 1 |
| Krittayapong, R | 1 |
| Bhuripanyo, K | 1 |
| Sitthisook, S | 1 |
| Chaothawee, L | 1 |
| Lai, MY | 1 |
| Azen, SP | 1 |
| Hjalmarson, A | 1 |
| Moser, M | 1 |
| Gorlin, R | 1 |
| Goldstein, S | 4 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Rotmensch, HH | 1 |
| Vlasses, PH | 1 |
| Ferguson, RK | 1 |
| Mazur, NA | 2 |
| Ostrovskaia, TP | 1 |
| Dokuchaeva, EA | 2 |
| Smirnova, TM | 2 |
| Ivanova, LA | 2 |
| Kulginskaya, IV | 1 |
| Ostrovskaya, TP | 1 |
| Svet, EA | 1 |
| Vygodin, VA | 1 |
| Ogawa, K | 1 |
| Ban, M | 1 |
| Kanayama, H | 1 |
| Ukai, M | 1 |
| Packer, DL | 1 |
| Coltorti, F | 1 |
| Smith, MS | 1 |
| Bardy, GH | 1 |
| Benson, DW | 1 |
| Edwards, SB | 1 |
| German, LD | 1 |
| Strasberg, B | 2 |
| Welch, W | 1 |
| Palileo, E | 1 |
| Swiryn, S | 1 |
| Bauernfeind, R | 1 |
| Rosen, KM | 1 |
| Schechter, E | 1 |
| Freeman, CC | 1 |
| Lazzara, R | 1 |
| Carlier, J | 1 |
| Hansteen, V | 2 |
| Møinichen, E | 1 |
| Lorentsen, E | 1 |
| Andersen, A | 1 |
| Strøm, O | 1 |
| Søiland, K | 1 |
| Dyrbekk, D | 1 |
| Refsum, AM | 1 |
| Tromsdal, A | 1 |
| Knudsen, K | 1 |
| Eika, C | 1 |
| Bakken, J | 1 |
| Smith, P | 1 |
| Hoff, PI | 1 |
| Morady, F | 1 |
| Scheinman, MM | 2 |
| Hess, DS | 1 |
| Sung, RJ | 1 |
| Shen, E | 1 |
| Shapiro, W | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Gruzdev, AK | 1 |
| McKenna, WJ | 2 |
| Goodwin, JF | 3 |
| Stewart, JR | 1 |
| Gibson, JK | 1 |
| Lucchesi, BR | 2 |
| Shand, DG | 1 |
| Pritchett, EL | 1 |
| Hammill, SC | 1 |
| Stargel, WW | 1 |
| Wagner, GS | 2 |
| Benatar, SR | 1 |
| Opie, LH | 1 |
| Maron, BJ | 2 |
| Roberts, WC | 2 |
| Epstein, SE | 2 |
| Butt, H | 1 |
| Moïse, NS | 1 |
| Moon, PF | 1 |
| Flahive, WJ | 1 |
| Brittain, D | 1 |
| Pride, HP | 1 |
| Lewis, BA | 1 |
| Zipes, DP | 1 |
| Lee, RJ | 1 |
| Gilmour, RF | 1 |
| Bryant, J | 1 |
| Dorostkar, PC | 1 |
| Eldar, M | 1 |
| Belhassen, B | 1 |
| Ross, J | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Killip, T | 1 |
| D'Amato, PH | 1 |
| Taylor, JB | 1 |
| Rios, JC | 1 |
| Gratsianskiĭ, NA | 1 |
| Esenbaeva, ZM | 1 |
| Zimin, IuV | 1 |
| Kuznetsova, GV | 1 |
| Miseiuk, NK | 1 |
| Bonchek, LI | 1 |
| Olinger, GN | 1 |
| Keelan, MH | 1 |
| Tresch, DD | 1 |
| Siegel, R | 1 |
| Edwards, JE | 1 |
| McAllister, HA | 1 |
| Foley, DD | 1 |
| Park, MK | 1 |
| Guntheroth, WG | 1 |
| Schwartz, GR | 1 |
| Shappell, SD | 2 |
| Marshall, CE | 2 |
| DeBusk, R | 1 |
| Tilkian, AG | 1 |
| Pfeifer, JF | 1 |
| Barry, WH | 1 |
| Lipton, MJ | 1 |
| Hultgren, HN | 1 |
| Miller, RR | 1 |
| Olson, HG | 1 |
| Amsterdam, EA | 1 |
| Mason, DT | 1 |
| Kniffen, FJ | 1 |
| Pelliccia, F | 1 |
| Cianfrocca, C | 1 |
| Romeo, F | 1 |
| Reale, A | 1 |
| Peters, RW | 4 |
| Shibleva, VV | 1 |
| Rubanovich, AI | 1 |
| Karpov, IuA | 1 |
| Podinovskaia, IaA | 1 |
| Ruda, MIa | 1 |
| de Paola, AA | 1 |
| Horowitz, LN | 1 |
| Marques, FB | 1 |
| Vattimo, AC | 1 |
| Terzian, AB | 1 |
| Ferreira, DF | 1 |
| Cirenza, C | 1 |
| Guiguer, N | 1 |
| Martinez Filho, EE | 1 |
| Byington, RP | 2 |
| Barker, A | 2 |
| Yusuf, S | 1 |
| Kleinebenne, A | 1 |
| Collins, MN | 1 |
| Billman, GE | 1 |
| Muller, JE | 1 |
| Byington, R | 3 |
| Friedman, LM | 2 |
| Furberg, CD | 1 |
| Dai, DZ | 1 |
| Kuang, LX | 1 |
| Chen, L | 1 |
| Huang, ML | 1 |
| Zhang, DL | 1 |
| Zhang, XA | 1 |
| Bassan, J | 1 |
| Kostis, JB | 1 |
| Wilson, AC | 1 |
| Sanders, MR | 1 |
| Kuck, KH | 1 |
| Miall, WE | 1 |
| Greenberg, G | 1 |
| Brennan, P | 1 |
| Caspi, A | 1 |
| Kusniec, J | 1 |
| Lewin, RF | 1 |
| Sclarovsky, S | 1 |
| Agmon, J | 1 |
| Parker, GW | 1 |
| Michael, LH | 1 |
| Entman, ML | 1 |
| Arensberg, D | 1 |
| Romhilt, DW | 1 |
| Laubach, C | 1 |
| Wilner, GW | 1 |
| Valladares, BK | 1 |
| Lemberg, L | 1 |
| Johnson, CT | 1 |
| Cowan, M | 1 |
| Johnson, GL | 1 |
| Ehrreich, SJ | 1 |
| el-Hage, AN | 1 |
| Balazs, T | 1 |
| Vedernikov, YP | 1 |
| Salerno, JA | 1 |
| Previtali, M | 1 |
| Panciroli, C | 1 |
| Klersy, C | 1 |
| Chimienti, M | 1 |
| Regazzi Bonora, M | 1 |
| Marangoni, E | 1 |
| Falcone, C | 1 |
| Guasti, L | 1 |
| Campana, C | 1 |
| Morgan, TO | 1 |
| Popov, VG | 1 |
| Martynov, IV | 1 |
| Alushkov, MV | 1 |
| Voronin, VA | 1 |
| Morganroth, J | 1 |
| Lichstein, E | 1 |
| Skinner, JE | 1 |
| Mason, JR | 1 |
| Marek, JC | 1 |
| Loeb, HS | 1 |
| Scanlon, PJ | 1 |
| Shah, PM | 1 |
| Adelman, AG | 1 |
| Wigle, ED | 1 |
| Gobel, FL | 1 |
| Burchell, HB | 1 |
| Hardarson, T | 1 |
| Curiel, R | 1 |
| De La Calzada, C | 1 |
| Oakley, CM | 1 |
| Alderman, EL | 1 |
| Coltart, DJ | 1 |
| Wettach, GE | 1 |
| Harrison, DC | 1 |
| England, RA | 1 |
| Csanády, M | 1 |
| Kiss, Z | 1 |
| McRae, JR | 1 |
| Rogers, MC | 1 |
| Canent, RV | 1 |
| Schneider, P | 1 |
| Schöne, D | 1 |
| Bock, K | 1 |
| Griegel, B | 1 |
| Gault, JH | 1 |
| Cantwell, J | 1 |
| Lev, M | 1 |
| Braunwald, E | 1 |
| Wrabec, K | 1 |
| Olley, PM | 1 |
| Fowler, RS | 1 |
| Norris, RM | 1 |
| Bensley, KE | 1 |
| Caughey, DE | 1 |
| Scott, PJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)[NCT00430612] | 7,057 participants (Actual) | Observational [Patient Registry] | 2009-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for propranolol and Death, Sudden
| Article | Year |
|---|---|
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
[Stress, cardiac arrhythmias and sudden death].
Topics: Animals; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Death, Sudden; Dogs; Humans; Propra | 1982 |
[Diagnosis and treatment of muscular subaortic stenosis].
Topics: Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Coronary Disease; Death, Sudden; Diagnosis, D | 1980 |
The natural history of hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Humans; Nifedipine; P | 1981 |
Effect of infarct size limitation by propranolol on ventricular arrhythmias after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Dogs; Humans; Myocardial Infarction; | 1982 |
Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Dose-Response Relatio | 1982 |
Regulation of cardiac vulnerability by the cerebral defense system.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brain; Brain Chemistry; Death, Sudden; Electr | 1985 |
Treatment of ventricular arrhythmias in ambulatory patients.
Topics: Ambulatory Care; Aneurysm; Coronary Disease; Death, Sudden; Electrocardiography; Humans; Pacemaker, | 1972 |
22 trials available for propranolol and Death, Sudden
| Article | Year |
|---|---|
Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial.
Topics: Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Death, Sudden; Defibrillators, Implantable | 2003 |
Beta Blocker Heart Attack Trial: design features.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Meth | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1982 |
beta-Blockers and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Diuretic | 1982 |
The Beta-Blocker Heart Attack Trial in perspective.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sud | 1983 |
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1984 |
Results of long-term propranolol treatment in myocardial infarction survivors with advanced grades of ventricular extrasystoles.
Topics: Cardiac Complexes, Premature; Death, Sudden; Electroencephalography; Heart Ventricles; Hemodynamics; | 1984 |
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
Topics: Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; Heart Arrest; Hum | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
The Norwegian propranolol trial in selected patients.
Topics: Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myoc | 1982 |
beta-Adrenergic blocking agents in the post-myocardial infarction patient.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; | 1979 |
The effect of coronary bypass surgery on exercise-induced ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Coronary Artery Bypass; Death, Sudden; Humans; Male; Physical Exertion; Propra | 1976 |
Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Hum | 1975 |
Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
Topics: Adult; Aged; Circadian Rhythm; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myocardial I | 1990 |
Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
Topics: Death, Sudden; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardi | 1990 |
The Beta-blocker Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary D | 1985 |
Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Human | 1988 |
Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol.
Topics: Analysis of Variance; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Drug Administra | 1988 |
Further results of the MRC treatment trial for mild hypertension.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Death, S | 1987 |
Mortality in the beta blocker heart attack trial: circumstances surrounding death.
Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; | 1987 |
Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Ele | 1985 |
54 other studies available for propranolol and Death, Sudden
| Article | Year |
|---|---|
[Long-term obsidan therapy of ischemic heart disease patients at high risk for sudden death].
Topics: Adult; Angina Pectoris; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden; Humans; Male; | 1982 |
Myocardial norepinephrine and cyclic amp concentration following myocardial ischemia--relation to ventricular fibrillation and sudden death.
Topics: Animals; Bucladesine; Coronary Disease; Cyclic AMP; Death, Sudden; Dogs; Female; Male; Myocardial In | 1983 |
Sudden death after left stellectomy in the long QT syndrome.
Topics: Adolescent; Arrhythmias, Cardiac; Death, Sudden; Electrocardiography; Female; Ganglia, Sympathetic; | 1984 |
Familial inducible torsade de pointes with normal QT interval.
Topics: Adult; Death, Sudden; Electric Stimulation; Electrocardiography; Female; Heart Ventricles; Humans; P | 1983 |
Afterdepolarizations as a mechanism for the long QT syndrome: electrophysiologic studies of a case.
Topics: Adult; Death, Sudden; Electrocardiography; Epinephrine; Female; Humans; Propranolol; Stress, Psychol | 1984 |
Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
Topics: Adult; Aged; Death, Sudden; Electrophysiology; Female; Heart Arrest; Humans; Male; Middle Aged; Pati | 1983 |
Sudden death in asthmatics receiving beta-blockers.
Topics: Asthma; Death, Sudden; Humans; Propanolamines; Propranolol; Timolol | 1982 |
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.
Topics: Adolescent; Adult; Age Factors; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Death, Sudden | 1982 |
[QT-syndrome includes 2 symptom complexes].
Topics: Child; Child, Preschool; Deafness; Death, Sudden; Electrocardiography; Humans; Infant; Propranolol; | 1981 |
Phenylephrine-induced ventricular arrhythmias in dogs with inherited sudden death.
Topics: Animals; Atropine; Cardiac Pacing, Artificial; Death, Sudden; Dogs; Female; Genetic Predisposition t | 1996 |
Unexpected sudden death during propranolol therapy in a patient with mild mesenteric venous myointimal hyperplasia.
Topics: Adult; Antihypertensive Agents; Contraindications; Death, Sudden; Female; Humans; Hyperplasia; Infar | 1998 |
Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Child, Preschool; Cohort Stud | 1999 |
Editorial: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Death, Sudden; Humans; Myocardial Infarction; Practol | 1976 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
Arrhythmias in myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac Complexes, Premature; D | 1976 |
Should premature ventricular beats be treated in the ambulatory patient? An antagonist's view.
Topics: Adult; Aged; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden; Electrocardiography; Fol | 1977 |
[Results of prospective studies of patients with unstable angina pectoris treated by conservative methods].
Topics: Adult; Aged; Angina Pectoris; Death, Sudden; Female; Follow-Up Studies; Humans; Male; Middle Aged; M | 1979 |
Management of sudden coronary death.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Female; | 1977 |
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.
Topics: Adolescent; Adult; Age Factors; Angiocardiography; Cardiomyopathy, Hypertrophic; Child; Death, Sudde | 1978 |
Long Q-T syndrome: a preventable form of sudden death.
Topics: Adolescent; Child; Death, Sudden; Electrocardiography; Follow-Up Studies; Humans; Male; Pedigree; Pr | 1978 |
Parasympathetic and sympathetic mechanisms in sudden death.
Topics: Aged; Bradycardia; Death, Sudden; Female; Heart Arrest; Humans; Male; Middle Aged; Parasympathetic N | 1977 |
Ballooning posterior leaflet syndrome: syncope and sudden death.
Topics: Adult; Arrhythmias, Cardiac; Death, Sudden; Female; Heart Valve Diseases; Humans; Mitral Valve; Phen | 1975 |
The value of exercise stress testing.
Topics: Adult; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Energy Metabolism; | 1975 |
Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Chlordiaz | 1975 |
Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients.
Topics: Adult; Cardiomyopathy, Hypertrophic; Death, Sudden; Follow-Up Studies; Humans; Prognosis; Propranolo | 1990 |
[Immediate and late prognosis in patients with unstable angina under medical treatment].
Topics: Adult; Aged; Angina, Unstable; Calcium Channel Blockers; Death, Sudden; Electrocardiography; Female; | 1990 |
Control of multiform ventricular tachycardia by propranolol in a child with no identifiable cardiac disease and sudden death.
Topics: Child; Death, Sudden; Electrocardiography; Female; Humans; Propranolol; Resuscitation; Tachycardia | 1990 |
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Pr | 1985 |
Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Coronary Disease; Coronary Vessels; Death, Sudden | 1989 |
Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
Topics: Adult; Aged; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myocardial Infarction; Posture | 1989 |
[Influence of propranolol withdrawal on the induction of sudden death in chronically infarcted rats by isoproterenol challenge].
Topics: Animals; Death, Sudden; Mice; Myocardial Infarction; Propranolol; Rats; Substance Withdrawal Syndrom | 1987 |
[Hereditary prolonged Q-T interval syndrome: Romano-Ward type].
Topics: Adolescent; Arrhythmias, Cardiac; Combined Modality Therapy; Death, Sudden; Heart Block; Humans; Lon | 1988 |
[Cardiac arrhythmia in hypertrophic cardiomyopathy. Diagnosis and therapy].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiac Pacing, Artificial; | 1987 |
Ventricular fibrillation in a patient with 'silent' mitral valve prolapse.
Topics: Adult; Amiodarone; Death, Sudden; Drug Therapy, Combination; Electrophysiology; Follow-Up Studies; H | 1988 |
An animal model to examine the response to environmental stress as a factor in sudden cardiac death.
Topics: Animals; Coronary Disease; Death, Sudden; Environment; Frontal Lobe; Hemodynamics; Humans; Models, B | 1987 |
Catecholamines, potassium, and beta-blockade.
Topics: Aged; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Epinephrine; Female; Humans; Hypokalemi | 1986 |
Relationship between the prolonged QTc interval and ventricular fibrillation.
Topics: Analysis of Variance; Death, Sudden; Electrocardiography; Female; Humans; Hypokalemia; Male; Middle | 1986 |
Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Bretylium Tosylate; Death, Sudden; Disease Models, Ani | 1986 |
Mechanisms of coronary spasm of isolated human epicardial coronary segments excised 3 to 5 hours after sudden death.
Topics: Acetylcholine; Adult; Angina Pectoris; Calcium; Calcium Channel Blockers; Coronary Disease; Coronary | 1986 |
Ventricular arrhythmias during acute myocardial ischaemia in man. The role and significance of R-ST-T alternans and the prevention of ischaemic sudden death by medical treatment.
Topics: Angina Pectoris, Variant; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Diltiazem; Electroc | 1986 |
Diuretics and myocardial infarction or sudden death.
Topics: Chlorothiazide; Death, Sudden; Humans; Hypertension; Male; Methyldopa; Middle Aged; Myocardial Infar | 1986 |
[Inderal in the acute and post-myocardial infarct periods].
Topics: Aged; Death, Sudden; Drug Evaluation; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; | 1986 |
Intravenous propranolol in the treatment of repetitive ventricular tachyarrhythmias during resuscitation from sudden death.
Topics: Aged; Arrhythmias, Cardiac; Death, Sudden; Female; Humans; Injections, Intravenous; Male; Middle Age | 1985 |
The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Cardiomyopathies; Child; Child, Preschool; Dea | 1974 |
Congestive and hypertrophic cardiomyopathies. A decade of study.
Topics: Blood Pressure; Cardiomegaly; Coronary Disease; Death, Sudden; Dilatation; Female; Heart Diseases; H | 1970 |
Coronary artery syndromes after sudden propranolol withdrawal.
Topics: Adult; Aged; Angina Pectoris; Death, Sudden; Electrocardiography; Humans; Male; Middle Aged; Myocard | 1974 |
Heritable Q-T prolongation without congenital deafness (Romano-Ward syndrome).
Topics: Adams-Stokes Syndrome; Adult; Deafness; Death, Sudden; Electrocardiography; Female; Heart Diseases; | 1973 |
Paroxysmal familial ventricular fibrillation.
Topics: Child; Death, Sudden; Electrocardiography; Electrophysiology; Humans; Lidocaine; Male; Propranolol; | 1974 |
Sudden death and the ballooning posterior leaflet syndrome. Detailed anatomic and histochemical investigation.
Topics: Adult; Aorta; Autopsy; Coronary Vessels; Death, Sudden; Electrocardiography; Female; Heart Auscultat | 1974 |
[The hereditary syndrome of QT-interval prolongation (Romano-Ward-Syndrome): differential diagnosis of syncopal attacks].
Topics: Adams-Stokes Syndrome; Adolescent; Adult; Autopsy; Death, Sudden; Diagnosis, Differential; Electroca | 1974 |
Fatal familial cardiac arrhythmias. Histologic observations on the cardiac conduction system.
Topics: Adolescent; Adult; Autopsy; Death, Sudden; Electrocardiography; Female; Heart Conduction System; Hum | 1972 |
[Prevention of arrhythmia as a cause of sudden death].
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Death, Sudden; Humans; Lidocaine; Propranolol | 1969 |
The surdo-cardiac syndrome and therapeutic observations.
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Blood Pressure; Cardiac Catheterization; Child; Child, | 1970 |
Hospital mortality in acute myocardial infarction.
Topics: Acute Disease; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; E | 1968 |